Search

Your search keyword '"E. Henry"' showing total 986 results

Search Constraints

Start Over You searched for: Author "E. Henry" Remove constraint Author: "E. Henry" Search Limiters Full Text Remove constraint Search Limiters: Full Text
986 results on '"E. Henry"'

Search Results

1. Distribution of a Foliage Disease Fungus Within Canopies of Mature Douglas-Fir in Western Oregon

2. An ecological perspective on living with fire in ponderosa pine forests of Oregon and Washington: Resistance, gone but not forgotten

3. Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?

4. Host, reproductive, and lifestyle factors in relation to quantitative histologic metrics of the normal breast

5. Proliferation kinetics and mineralization properties of MC3T3‐E1 cells on whey protein isolate scaffolds for bone tissue regeneration

6. Criando gallinas ponedoras en el patio

8. Sialylation of chitosan to mitigate Aβ toxicity

9. Quality assessment of consumer‐facing websites on sodium reduction

10. Outdoor air pollution and histologic composition of normal breast tissue

11. Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence

14. Multimodal mapping of cell types and projections in the central nucleus of the amygdala

15. Sulfide-linked 3,4,5-trimethoxyphenyl-thiosemicarbazide/triazole hybrids: Synthesis, antioxidant, antiglycation, DNA cleavage and DNA molecular docking studies

17. Normative Data for the NeuroCom Sensory Organization Test in United States Military Academy Boxers

20. National hydrologic connectivity classification links wetlands with stream water quality

21. Multimodal Analysis of STRADA Function in Brain Development

25. Mechanistic target of rapamycin is necessary for changes in dendritic spine morphology associated with long-term potentiation

27. The Effects of Baseline Impaired Global Cognitive Function on the Efficacy and Cognitive Effects of Electroconvulsive Therapy in Geriatric Patients: A Retrospective Cohort Study

28. Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing

29. Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis

30. Raising Backyard Chickens for Eggs

31. Supplementary Materials and Methods, Supplementary 1-7 and Supplementary Table 1. from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

32. Data from ERK Inhibition Improves Anti–PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal Adenocarcinoma

34. Data from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe

35. Figure S1 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe

36. Table S1 from Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe

37. Supplemental Figure 4 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

38. Supplemental Figure 2 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

40. Supplemental Methods from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

41. Supplementary Data from A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

42. Supplemental Figure 1 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

43. Supplemental Figure 3 from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

44. Supplemental Figure 5 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

45. Supplemental Figure 2 from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

46. Data from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

47. Supplemental Figure 3 from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

49. Supplemental Figure 1 from The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models

50. Data from Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [64Cu]Cu-NOTA-anti-CD8 PET

Catalog

Books, media, physical & digital resources